Loading Events

Past Events › BTS Courses and Webinars

Events Search and Views Navigation

Event Views Navigation

December 2017

ACT webinar on Animal Models of Disease for Nonclincial Safety Assessment

06/12/2017 @ 11:00 am - 12:30 pm

ACT sponsors quarterly webinars on current topics in toxicology, including primarily drug and chemical safety assessments. Presenters are experts in their field, with backgrounds in government, industry or academia. The goal of the webinar series is to provide accessible education on topics in toxicology to ACT members and, more broadly, members of the toxicology community worldwide. ACT Webinars are reaching thousands, with collaborations spanning the globe while increasing individual and corporate ACT membership and participation. Hosted by the American College…

Find out more »

Basic Training in Toxicology E-Learning Series: Module 12 – Ecotoxicology and Environmental Toxicology

13/12/2017

The American College of Toxicology (ACT) and the British Toxicology Society (BTS) are offering a new training in toxicology webinar series. The intention of these educational modules is to provide twelve modules of basic toxicology training by experts in the field to professionals and students worldwide. The live webinars will be offered every other month in 60–75-minute segments followed by 15 minutes for questions and answers. Registrants will have access to the webinar recordings for thirty days following the live…

Find out more »

March 2018

ACT Webinar: Preparing for Regulatory Interactions: How Much is Enough?

07/03/2018 @ 4:00 pm - 5:30 pm

Speaker: Janice Lansita, PhD, DABT, ToxStrategies, Inc. Abstract: Productive industry interactions with regulatory authorities are critical for clinical development. However, it can be challenging to determine how much preparatory time and effort will be needed to accomplish the desired goals. How many studies need to be conducted and how much information provided, without wasting resources or overwhelming regulators? Several key questions should be considered in preparing for a regulatory interactions or meetings. These include: What key issue(s) need to be…

Find out more »

July 2018

Practical Application of Toxicology in Drug Development

23/07/2018 @ 9:00 am - 27/07/2018 @ 12:00 pm
The Møller Centre, Cambridge United Kingdom

Co-organised by the British Toxicology Society and the American College of Toxicology 23-27 July 2018 The Møller Centre, Cambridge, United Kingdom Early Bird Registration deadline: 1st June 2018 This highly acclaimed course will provide training in Toxicology as applied in Drug Development to scientists from all parts of the world. Participants will obtain an overall understanding of the principles of nonclinical safety evaluation with emphasis on the practical application of these principles and interpretation of nonclinical safety data. Regulatory toxicology in drug…

Find out more »

September 2018

The Veterinary Pathologist’s Role in the 3Rs

19/09/2018 @ 11:30 am - 1:00 pm
Free

You are Invited to Participate in a Free Educational Webinar The Veterinary Pathologist’s Role in the 3Rs Wednesday, September 19, 2018 Time: 11:00 AM ET Hosted by the American College of Toxicology and the Society of Toxicologic Pathology In Collaboration with the British Toxicology Society and the Teratology Society Speaker: Renee Hukkanen, DVM, MS, DACVP Senior Scientist, Pathology, Eisai AiM Institute | Eisai Inc. Speaker: Niraj K. Tripathi, BVSc, MVSc, PhD, DACVP Clinical Pathologist, Covance Laboratories Inc. Speaker: Sean P.…

Find out more »

December 2018

WEBINAR: Safety Assessment of Monoclonal Antibodies for Immunosuppressants and Anti-Inflammatory Agents

19/12/2018 @ 4:00 pm - 5:30 pm

This webinar, will start with an introduction to mAbs that target specific components of both the autoimmune response and the inflammatory cascade, followed by in-depth discussions of the following topics and speakers:   Introduction: Monoclonal Antibodies for the Treatment of Immune-Mediated Inflammatory Disease Simone Nicholson, PhD, DABT Senior Toxicologist, Biologics Safety Assessment, MedImmune LLC     Immune Safety Assessments for Immunosuppressive Agents: Tools and Applications Hervé Lebrec, PharmD, PhD, DABT Scientific Director, Nonclinical Safety Sciences, Amgen Inc. Carcinogenicity Assessment of Biologics    …

Find out more »
+ Export Events
Page 1 of 3